Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers. Factors such as rising prevalence of different forms of cancer, technological  advancements in the field of ablation, rising awareness regarding the benefits offered by ablation procedures over conventional surgical procedures and rising number of hospitals, surgical and ablation centers are driving the growth of tumor ablation market globally.

This report on global trigeminal neuralgia treatment market studies various drugs used for treatment of trigeminal neuralgia along with pipeline analysis of upcoming potential drugs. Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. According to the International Association for the Study of Pain the incidence of Trigeminal Neuralgia is 12 per 100,000 persons per year.

Surgical mesh is a medical device constructed by using synthetic materials or animal tissue and used to provide extra support to weak or damaged tissue. Surgical polypropylene mesh widely adopted in the market due to its stability, durability, low infection risk and high mechanical strength.

Substance abuse is a compulsive, excessive, and self-damaging use of habit forming drugs or substances. Factors such as rising patient awareness, higher treatment seeking rate, increased government intervention, higher number of addicted population and encouragement to curb substance abuse in all countries are driving the growth of substance abuse treatment market globally.

The sterility testing of compounded sterile preparations have come under scrutiny in the light of the newly passed federal drug quality and security act (DQSA), pub. L No. 113-54 which stresses on the validation of the biological indicators for the completion of sterility testing. Biological indicators such as Geobacillus stearothermophilus endospores which is used due to the advantages provided such as 6 log efficiency challenge, in process testing controls of the sterile preparations to reduce the risks of false positives.

The purpose of this research study titled ‘Specialty Enzymes Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global specialty enzymes market. This report presents and analyzes the major trends prevalent in the global specialty enzymes market and the market size and forecast.

Soft tissue repair process is characterized by replacement of injured or destroyed tissues by healthy tissues. Factors such as increasing incidence of soft tissue injuries, lack of substitutes for soft tissue repair surgery, rising treatment awareness and increasing demand for minimally invasive procedure are driving the growth of soft tissue repair market globally.

Pyrogens are a heterogeneous group of microbial and non-microbial substances that cause fever. Most common and potent variants lipopolysaccharides or endotoxins; gram positive bacteria are also some sources of pyrogens. Since contamination from pyrogens in biotherapeutics, medical devices, pharmaceuticals and cosmetics can possibly compromise health and wellbeing, it is mandatory for manufacturers to check on the limit of pyrogen.

The report titled “Pulmonary Drug Delivery Devices Market- Growth, Future Prospects, and Competitive Analysis, 2017 – 2025” offers strategic insights into the overall pulmonary drug delivery devices market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of technology, application, and different geographies.

Prenatal vitamin supplements consist of a variety of vitamins and minerals that are essential for the healthy development of the unborn baby. Vitamins and minerals such as iron, calcium, and folic acid are vital for proper fetal growth, development, and healthy adult living.

General population studies have reported that 7 to 8% adults currently have chronic neuropathic pain, where the reported incidence is of 8 cases per 1,000 individuals per year. In the U.K. alone, 26% individuals with diabetes experience peripheral neuropathic pain. Globally, this figure translates to approximately 50 million individuals, which will further increase as is anticipated that the prevalence of diabetes will grow to an estimated 4.4% by 2030. Anticonvulsant pregabalin (Lyrica, Pfizer) is among the most widely spread drug for neuropathic pain.

Periodontal therapeutics are the non-surgical treatment for the periodontal diseases. Periodontal diseases are the infections of the structures around the teeth including the gums, the cementum that covers the root, the periodontal ligament and the aveolar bone.

A peptic ulcer is forms of painful sores that develops on the mucosal lining of the stomach, small intestine or lower esophagus. Increase in prevalence of H. Pylori infection, improved diagnostic techniques, easy availability of treatment medication, preferable use of peptic ulcer medication over surgery, increase in rate of smocking and over use of NSAIDs are driving the growth of peptic ulcer drugs market globally.

Osteoporosis is a common disease characterized by porous bone structure, lower bone mass and reduced bone strength. Osteoporosis is a condition where the regrowth of bone is slower than the breakage of bone. It is estimated that worldwide around 200 million population are affected with osteoporosis and it causes around 9 million fractures annually which is a major public concern as the estimated cost of osteoporosis is about 19 billion in United States only.

Orthopedic braces and supports are the products used to change or alter the functioning of musculoskeletal system. These devices are mainly used for rehabilitation from illness, trauma, and even congenital conditions. At present, the global orthopedic braces and supports market is driven by baby boomer population, high focus on improving quality of life, innovation in nature of braces and supports, rising incidence of sports injuries and others. Conversely, restricted reimbursement and payment models, and healthcare budgets put constraints to the growth of this market.

Omega 3 fatty acids are a type of fat that are considered essential for overall health of humans. A lot of health experts recommend the same and a lot of research has went into discovering the many health benefits of omega-3 fatty acids.

Ocular drug delivery is a cumbersome challenge to the researchers and medical field as the physiology and anatomy of eye is relatively complex. The conventional drugs are available in the market, but they are lesser efficient to act some particular sites of eye. Therefore research for enhanced eye treatment is still an ongoing process to develop advanced technology with better outcome. Topical treatment is the conventional approach and still dominates the market owing to easy application and in terms of affordability.

Nuclear medicine/ radiopharmaceuticals are agents used to diagnose certain medical problems or treat certain diseases condition. Increasing awareness of radiopharmaceuticals, growing number of pharmaceutical companies and rising research institutes are major factors that assisting the growth of nuclear medicine/ radiopharmaceuticals market globally.

Pain is a symptom, fundamentally results from any injury, infection, disorder or disease. Globally more than 1.5 billion people suffer from different types of pain and among all, lower back pain, neck pain, headache and facial pain are most common.

Myelodysplastic syndrome (MDS) is type of cancer and it considered as group of blood and bone marrow disorders and involves production of abnormal and immature blood cells. It is anticipated that MDS treatment drugs market will show significant market growth over the forecast period due to rising prevalence of MDS, increase in spending in the healthcare system, growing investments in R&D for MDS treatment and strong presence of ideal pipeline drugs. Expected launch of late stage pipeline drugs such as JNJ-63935937, MLN-4924, NSC-39069 and rigosertib is anticipated to drive significant market growth over the forecast period 2017-2025.